GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.
Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...
GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.
Related Articles
XUANZHUBIO-B(02575): Abnormal share price movement; preliminary discussions are ongoing with a certain party regarding a potential acquisition.
Anhui Ankai Automobile (000868.SZ): Provincial Investment Group plans to reduce its shareholding by no more than 0.85% of the company's shares.
Sichuan Biokin Pharmaceutical (688506.SH) subsidiary plans to invest US$5 million in innovative drug company Connexus Therapeutics.
XUANZHUBIO-B(02575): Abnormal share price movement; preliminary discussions are ongoing with a certain party regarding a potential acquisition.
Anhui Ankai Automobile (000868.SZ): Provincial Investment Group plans to reduce its shareholding by no more than 0.85% of the company's shares.
Sichuan Biokin Pharmaceutical (688506.SH) subsidiary plans to invest US$5 million in innovative drug company Connexus Therapeutics.
RECOMMEND
